Bicocca Open Archive

Logo unimib boa
BIONDI, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 56.684
AS - Asia 29.368
EU - Europa 25.137
SA - Sud America 4.435
AF - Africa 487
Continente sconosciuto - Info sul continente non disponibili 53
OC - Oceania 49
Totale 116.213
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 55.400
SG - Singapore 10.797
CN - Cina 6.725
IT - Italia 5.564
HK - Hong Kong 4.769
RU - Federazione Russa 4.302
VN - Vietnam 3.909
BR - Brasile 3.616
DE - Germania 3.185
SE - Svezia 2.982
IE - Irlanda 2.715
UA - Ucraina 1.743
GB - Regno Unito 1.359
CA - Canada 920
FI - Finlandia 703
FR - Francia 649
IN - India 595
ID - Indonesia 484
KR - Corea 475
AT - Austria 434
TR - Turchia 363
NL - Olanda 334
AR - Argentina 329
BD - Bangladesh 257
MX - Messico 240
PL - Polonia 234
ZA - Sudafrica 228
JP - Giappone 221
DK - Danimarca 202
ES - Italia 162
BE - Belgio 158
EC - Ecuador 131
IQ - Iraq 123
CO - Colombia 91
PK - Pakistan 86
VE - Venezuela 74
IR - Iran 63
SA - Arabia Saudita 63
CH - Svizzera 59
EG - Egitto 59
AE - Emirati Arabi Uniti 58
PY - Paraguay 53
LT - Lituania 52
UZ - Uzbekistan 51
MA - Marocco 49
CZ - Repubblica Ceca 48
PE - Perù 44
CL - Cile 43
BG - Bulgaria 41
AU - Australia 38
EU - Europa 38
RO - Romania 37
JO - Giordania 35
KE - Kenya 33
IL - Israele 32
PH - Filippine 32
GR - Grecia 31
KZ - Kazakistan 30
UY - Uruguay 30
TN - Tunisia 28
AZ - Azerbaigian 26
NO - Norvegia 22
AL - Albania 21
JM - Giamaica 20
MY - Malesia 20
PA - Panama 20
TW - Taiwan 20
PT - Portogallo 19
DO - Repubblica Dominicana 18
DZ - Algeria 18
LB - Libano 18
NP - Nepal 18
BO - Bolivia 16
OM - Oman 16
CR - Costa Rica 13
KG - Kirghizistan 13
LV - Lettonia 13
GT - Guatemala 12
HN - Honduras 12
SN - Senegal 12
TH - Thailandia 12
NZ - Nuova Zelanda 10
AM - Armenia 9
NG - Nigeria 9
BA - Bosnia-Erzegovina 8
CI - Costa d'Avorio 8
ET - Etiopia 8
HR - Croazia 8
HU - Ungheria 8
RS - Serbia 8
TT - Trinidad e Tobago 8
A2 - ???statistics.table.value.countryCode.A2??? 7
LK - Sri Lanka 7
NI - Nicaragua 7
PS - Palestinian Territory 7
SC - Seychelles 7
SK - Slovacchia (Repubblica Slovacca) 7
BH - Bahrain 6
BY - Bielorussia 5
EE - Estonia 5
Totale 116.107
Salva come PNG Salva come JPEG
Città #
Ann Arbor 8.965
Singapore 6.167
Ashburn 4.826
Hong Kong 4.746
Woodbridge 4.520
Fairfield 4.226
Houston 3.567
Chandler 2.783
Dublin 2.617
Wilmington 2.440
Frankfurt am Main 1.989
Jacksonville 1.841
Seattle 1.730
Milan 1.522
Cambridge 1.460
New York 1.439
Dearborn 1.266
Santa Clara 1.208
Ho Chi Minh City 1.174
Beijing 1.133
Princeton 1.003
Hefei 946
Hanoi 914
Los Angeles 894
Dallas 825
Nanjing 528
Chicago 474
Lawrence 474
Altamura 459
Moscow 454
Seoul 446
Shanghai 435
Jakarta 380
The Dalles 379
Buffalo 357
São Paulo 345
Vienna 322
Lachine 309
San Diego 284
Munich 274
London 220
Guangzhou 209
Dong Ket 200
Rome 198
Helsinki 194
Nuremberg 183
Toronto 183
Warsaw 182
Boardman 175
Tokyo 170
Andover 166
Council Bluffs 161
Denver 154
Lissone 154
Nanchang 153
Montreal 151
Brussels 146
Changsha 144
Brooklyn 138
Rio de Janeiro 132
Shenyang 131
Hebei 128
Tianjin 127
Johannesburg 122
Stockholm 121
Salt Lake City 111
Orem 109
Poplar 107
Monza 106
Turku 104
Jinan 102
Haiphong 100
Chennai 98
Phoenix 98
Ottawa 96
Da Nang 88
Hangzhou 88
Atlanta 87
Fremont 86
Norwalk 85
Lappeenranta 83
San Jose 83
Boston 82
Falls Church 82
Jiaxing 80
Mexico City 79
Ha Long 78
Brasília 77
Zhengzhou 75
Fuzhou 74
Biên Hòa 73
Tampa 73
Turin 72
Pune 70
Bologna 69
Manchester 69
Hải Dương 66
Kent 65
Mumbai 65
Belo Horizonte 62
Totale 77.105
Salva come PNG Salva come JPEG
Nome #
miRNA-regulated gene expression differs in celiac disease patients according to the age of presentation 504
Intraperitoneal adoptive transfer of mesenchymal stem cells enhances recovery from acid aspiration acute lung injury in mice 464
Prenatal Origin of Pediatric Leukemia: Lessons From Hematopoietic Development 457
BEYOND THE TUMOUR: CHILDHOOD CANCER PREDISPOSING SYNDROMES [Guardare oltre il tumore: le cancer-predisposingsyndrome in età pediatrica] 455
Four Additional Doses of PEG-L-Asparaginase during the Consolidation Phase in the AIEOP-BFM ALL 2009 Protocol Do Not Improve Outcome and Increase Toxicity in High-Risk ALL: Results of a Randomized Study 453
Molecular Pathways and Respiratory Involvement in Lysosomal Storage Diseases 448
Magnitude and dynamics of the T-cell response to SARS-CoV-2 infection at both individual and population levels 447
Maturation signatures of conventional dendritic cell subtypes in COVID-19 suggest direct viral sensing 441
Results of a multicenter universal newborn screening program for sickle cell disease in Italy: A call to action 432
Enzymatic replacement therapy for Hunter disease: Up to 9 years experience with 17 patients 425
Treatment of Graft versus Host Disease with Mesenchymal Stromal Cells: A Phase I Study on 40 Adult and Pediatric Patients 423
Hepatic granulomatous lesions caused by systemic bartonella vinsonii subsp. arupensis infection in a child 415
Pro-inflammatory cytokines favor the emergence of ETV6-RUNX1-positive pre-leukemic cells in a model of mesenchymal niche 410
Acute myeloid leukaemia niche regulates response to L-asparaginase 406
Late mortality and causes of death among 5-year survivors of childhood cancer diagnosed in the period 1960–1999 and registered in the Italian Off-Therapy Registry 400
First evidence of a paediatric patient with Cornelia de Lange syndrome with acute lymphoblastic leukaemia 395
Acute Myeloid Leukemia Targeting by Chimeric Antigen Receptor T Cells: Bridging the Gap from Preclinical Modeling to Human Studies 394
Phase II Study of Sequential Infusion of Donor Lymphocyte Infusion and Cytokine-Induced Killer Cells for Patients Relapsed after Allogeneic Hematopoietic Stem Cell Transplantation 391
Cardiofaciocutaneous syndrome and immunodeficiency: data from an international multicenter cohort 390
NIPBL: a new player in myeloid cells differentiation 389
Predictive value of minimal residual disease in philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies 387
IKZF1 plus defines a new minimal residual disease-dependent very-poor prognostic profile in pediatric b-cell precursor acute lymphoblastic leukemia 376
Clinical features and outcome of SIL/TAL1-positive t-cell acute lymphoblastic leukemia in children and adolescents: A 10-year experience of the AIEOP group 375
Sleeping Beauty-engineered CAR T cells achieve anti-leukemic activity without severe toxicities 374
Hodgkin lymphoma in a patient with mosaic trisomy 18: First clinical observation 369
Development of advanced therapies in Italy: Management models and sustainability in six Italian cell factories 364
Studio preliminare sul profilo emotivo di un campione di bambini guariti da leucemia linfoblastica acuta 364
Pentraxin 3 plasma levels at graft-versus-host disease onset predict disease severity and response to therapy in children given haematopoietic stem cell transplantation 357
Targeting CD33 in Chemoresistant AML Patient-Derived Xenografts by CAR-CIK Cells Modified with an Improved SB Transposon System 356
A simple RNA target capture NGS strategy for fusion genes assessment in the diagnostics of pediatric B-cell acute lymphoblastic leukemia 355
Phenotypical and Functional Characterization of Mesenchymal Stem Cells Derived From Patients Affected by Schwachman-Diamond Syndrome 353
Preclinical Efficacy and Safety of CD19CAR Cytokine-Induced Killer Cells Transfected with Sleeping Beauty Transposon for the Treatment of Acute Lymphoblastic Leukemia 352
Mesenchymal stromal cells from Shwachman-Diamond syndrome patients fail to recreate a bone marrow niche in vivo and exhibit impaired angiogenesis 352
Moral distress in nurses in oncology and haematology units 344
Mesenchymal stromal cells for the treatment of graft-versus-host disease: understanding the in vivo biological effect through patient immune monitoring 343
Combined CAR-T/HSCT approach in a patient with refractory acute lymphoblastic leukemia and cystic fibrosis 342
ActivinA: a new leukemia-promoting factor conferring migratory advantage to B-cell precursor-acute lymphoblastic leukemic cells 338
Full GMP-Compliant Validation of Bone Marrow-Derived Human CD133+ Cells as Advanced Therapy Medicinal Product for Refractory Ischemic Cardiomyopathy 337
GMP-grade preparation of biomimetic scaffolds with osteo-differentiated autologous mesenchymal stromal cells for the treatment of alveolar bone resorption in periodontal disease 336
Immunogenotype changes prevail in relapses of young children with TEL-AML1-positive acute lymphoblastic leukemia and derive mainly from clonal selection 327
Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection 324
Fludarabine as a cost-effective adjuvant to enhance engraftment of human normal and malignant hematopoiesis in immunodeficient mice 324
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 324
Absent B cells, agammaglobulinemia, and hypertrophic cardiomyopathy in folliculin-interacting protein 1 deficiency 321
Activin A contributes to the definition of a pro-oncogenic bone marrow microenvironment in t(12;21) preleukemia 319
Oral nutritional supplementation in children treated for cancer in low- and middle-income countries is feasible and effective: The experience of the children's hospital manuel de jesus rivera "la mascota" in Nicaragua 319
A novel EP300 mutation associated with Rubinstein-Taybi syndrome type 2 presenting as combined immunodeficiency 318
The histone deacetylase inhibitor givinostat (ITF2357) exhibits potent anti-tumor activity against CRLF2-rearranged BCP-ALL 317
Diagnosis and monitoring of PML-RARA-positive acute promyelocytic leukemia by qualitative RT-PCR 315
Safe and Effective Treatment of Graft Versus Host Disease with Platelet Lysate-Expanded Human Mesenchymal Stromal Cells: A Phase 1 Study On 47 Adult and Pediatric Patients 314
A new case report of severe mucopolysaccharidosis type VII: Diagnosis, treatment with haematopoietic cell transplantation and prenatal diagnosis in a second pregnancy 11 Medical and Health Sciences 1114 Paediatrics and Reproductive Medicine 314
From Adjustment to Thriving: Exploring Well-Being in Young Adult Survivors of Childhood Cancer and Their Siblings 314
Healthcare costs and resources utilization in children with difficult-to-control asthma treated with biologic therapies: A population-based cohort study 313
Interleukin-17-producing t-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation 313
Globalization of pediatric research: Pharmacological RCTs in Latin America 313
A second update on mapping the human genetic architecture of COVID-19 309
TNFRSF13C (BAFFR) positive blasts persist after early treatment and at relapse in childhood B-cell precursor acute lymphoblastic leukaemia 308
T cells stimulated by CD40L positive leukemic blasts-pulsed dendritic cells meet optimal functional requirements for adoptive T-cell therapy 307
Antileukemic efficacy of BET inhibitor in a preclinical mouse model of MLL-AF4 + infant ALL 307
Helmet CPAP to treat hypoxic pneumonia outside the ICU: an observational study during the COVID-19 outbreak 307
Prevalence of Immunological Defects in a Cohort of 97 Rubinstein–Taybi Syndrome Patients 305
Balance of Anti-CD123 Chimeric Antigen Receptor Binding Affinity and Density for the Targeting of Acute Myeloid Leukemia 304
Perturbations of the T-cell receptor repertoire in response to SARS-CoV-2 in immunocompetent and immunocompromised individuals 302
Hematopoietic Stem Cell (HSC)-Independent Progenitors Are Susceptible to Mll-Af9-Induced Leukemic Transformation 300
Biallelic PI4KA Mutations Disrupt B-Cell Metabolism and Cause B-Cell Lymphopenia and Hypogammaglobulinemia 299
Reduced-Intensity delayed intensification in standard-Risk pediatric acute lymphoblastic leukemia defined by undetectable minimal residual disease: Results of an international randomized trial (AIEOP-BFM ALL 2000) 299
Immunotherapy of acute leukemia by chimeric antigen receptormodified lymphocytes using an improved Sleeping Beauty transposon platform 298
Children with cancer in the time of COVID-19: An 8-week report from the six pediatric onco-hematology centers in Lombardia, Italy 298
Acute myeloid leukemia shapes the bone marrow stromal niche in vivo 298
Human umbilical cord blood-borne fibroblasts contain marrow niche precursors that form a bone/marrow organoid in vivo 297
Regulatory T cells and extracorporeal photochemotherapy: correlation with clinical response and decreased frequency of proinflammatory T cells. 296
Engineered T cells towards TNFRSF13C (BAFFR): a novel strategy to efficiently target B-cell acute lymphoblastic leukaemia 296
Transposon-Based CAR T Cells in Acute Leukemias: Where are We Going? 296
Mapping the human genetic architecture of COVID-19 292
Location First: Targeting Acute Myeloid Leukemia Within Its Niche 289
Antitumour activity of trabectedin in myelodysplastic/myeloproliferative neoplasms 288
Human aplastic anaemia-derived mesenchymal stromal cells form functional haematopoietic stem cell niche in vivo 285
Two siblings presenting with novel ADA2 variants, lymphoproliferation, persistence of large granular lymphocytes, and T-cell perturbations 284
Mesenchymal stromal cell-derived PTX3 promotes wound healing via fibrin remodeling 283
Epigenetic silencing of BIM in glucocorticoid poor-responsive pediatric acute lymphoblastic leukemia, and its reversal by histone deacetylase inhibition 282
Stable Expression Of Chimeric Antigen Receptors (CARs) By Sleeping Beauty-Mediated Gene Transfer and Efficient Expansion Of Leukemia-Specific Cytokine-Induced Killer (CIK) Cells 282
Mesenchymal stromal cell-secreted chemerin is a novel immunomodulatory molecule driving the migration of ChemR23-expressing cells 281
CXCR4-MODIFIED CD33.CAR-CIK WITH ENHANCED BONE MARROW HOMING IN ACUTE MYELOID LEUKEMIA 279
Optimization of PCR-based minimal residual disease diagnostics for childhood acute lymphoblastic leukemia in a multi-center setting 276
Mesenchymal stromal cells do not increase the risk of viral reactivation nor the severity of viral events in recipients of allogeneic stem cell transplantation 276
Lessons after the early management of the COVID-19 outbreak in a pediatric transplant and hemato-oncology center embedded within a COVID-19 dedicated hospital in Lombardia, Italy. Estote parati 276
Cytoskeletal Regulatory Gene Expression and Migratory Properties of B Cell Progenitors are Affected by the ETV6-RUNX1 Rearrangement 275
Drug-induced immunophenotypic modulation in childhood ALL: implications for minimal residual disease detection 273
Platelet-lysate-expanded mesenchymal stromal cells as a salvage therapy for severe resistant graft-versus-host disease in a pediatric population 273
Crescere dopo il tumore: Le emozioni dei bambini guariti da leucemia linfoblastica acuta a confronto con quelle di altre popolazioni 273
Neonatal combination therapy improves some of the clinical manifestations in the Mucopolysaccharidosis type I murine model 271
Suppressors and activators of JAK-STAT signaling at diagnosis and relapse of acute lymphoblastic leukemia in Down syndrome 269
AIEOP-BFM consensus guidelines 2016 for flow cytometric immunophenotyping of Pediatric acute lymphoblastic leukemia 269
An immune-based biomarker signature is associated with mortality in COVID-19 patients 268
Asparagine levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia treated with pegylated-asparaginase in the induction phase of the AIEOP-BFM ALL 2009 study 267
Characterization of Plated Lysate Cultured Mesenchymal Stromal Cells and Their Potential Use in Tissue-Engineered Osteogenic Devices for the Treatment of Bone Defects 266
Autologous Purified Peripheral Blood Stem Cell Transplantation Compare to Chemotherapy in Childhood Acute Lymphoblastic Leukemia after Low-Risk Relapse 266
Long-term follow up of pediatric Philadelphia positive acute lymphoblastic leukemia treated with the EsPhALL2004 study: High white blood cell count at diagnosis is the strongest prognostic factor 265
Poor prognosis for P2RY8-CRLF2 fusion but not for CRLF2 over-expression in children with intermediate risk B-cell precursor acute lymphoblastic leukemia 264
Characterization of in vitro migratory properties of anti-CD19 chimeric receptor-redirected CIK cells for their potential use in B-ALL immunotherapy 263
Totale 33.263
Salva come PNG Salva come JPEG
Categoria #
all - tutte 399.532
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 399.532
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20217.100 0 0 0 0 0 1.045 1.103 1.075 915 1.207 725 1.030
2021/20227.503 529 839 954 528 429 516 350 389 572 540 597 1.260
2022/202311.443 1.435 3.409 836 1.011 707 1.702 194 681 748 95 410 215
2023/20248.951 310 290 438 479 1.139 2.268 1.640 318 756 190 282 841
2024/202522.169 1.151 2.332 1.267 1.023 1.856 899 1.489 801 2.275 3.119 1.990 3.967
2025/202629.522 6.909 3.803 3.936 6.022 6.404 2.448 0 0 0 0 0 0
Totale 119.179